These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 301777)

  • 61. Pyrimethamine effect on folate metabolism.
    Herbert V; Waxman S
    N Engl J Med; 1969 Sep; 281(10):564-5. PubMed ID: 5800521
    [No Abstract]   [Full Text] [Related]  

  • 62. Pyrimethamine poisoning.
    Akinyanju O; Goddell JC; Ahmed I
    Br Med J; 1973 Oct; 4(5885):147-8. PubMed ID: 4543103
    [No Abstract]   [Full Text] [Related]  

  • 63. The effects of folic or folinic acid on the toxicity of pyrimethamine in dogs.
    Castles TR; Kintner LD; Lee CC
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):447-59. PubMed ID: 5316905
    [No Abstract]   [Full Text] [Related]  

  • 64. Daraprim as an antagonist of folic and folinic acids.
    HITCHINGS GH
    Trans R Soc Trop Med Hyg; 1952 Sep; 46(5):467-73; discussion, 498-508. PubMed ID: 12995436
    [No Abstract]   [Full Text] [Related]  

  • 65. An enzyme inhibition assay for 2,4-diamino-5-(3'4'-dichlorophenyl)-6-methylpyrimidine (DDMP,NSC 19494).
    Calvert AH; Cridland JS; Harrap KR
    J Clin Pathol; 1977 Dec; 30(12):1154-7. PubMed ID: 604362
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studies on the transport and distribution of diaminopyrimidines in L5178Y lymphoblasts in cell culture.
    Hill BT; Price LA; Harrison SI; Goldie JH
    Biochem Pharmacol; 1975 Feb; 24(4):535-8. PubMed ID: 1078627
    [No Abstract]   [Full Text] [Related]  

  • 67. Lack of effect of folic-acid administration on cerebral metabolism.
    Moir AT; Williams IR; Halliday J
    Lancet; 1971 Oct; 2(7728):798-800. PubMed ID: 4106611
    [No Abstract]   [Full Text] [Related]  

  • 68. Long plasma half-life of pyrimethamine.
    Nichol CA
    Lancet; 1973 Jul; 2(7821):161. PubMed ID: 4124093
    [No Abstract]   [Full Text] [Related]  

  • 69. Clinical effects of the dichloro and monochlorophenyl analogues of diamino pyrimidine: antagonists of folic acid.
    MURPHY ML; ELLISON RR; KARNOFSKY DA; BURCHENAL JH
    J Clin Invest; 1954 Oct; 33(10):1388-96. PubMed ID: 13201645
    [No Abstract]   [Full Text] [Related]  

  • 70. [Antagonism between thymine & folic acid on the tumor-inhibiting effects of pyrimidine analogs].
    DI MARCO A; GAETANI M
    Tumori; 1958; 44(4):296-301. PubMed ID: 13603833
    [No Abstract]   [Full Text] [Related]  

  • 71. On the Site of Action of Amethopterin.
    Condit PT
    Science; 1961 Nov; 134(3488):1421. PubMed ID: 17795770
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Initial experiments with the collective prevention of malaria in Indo-China with diamino-2-4(chloro-4-phenyl)5-ethyl-6-pyrimidine 50-63 B.W. or 4653 R.P)].
    CANET J; FARINAUD E
    Bull Soc Pathol Exot Filiales; 1952; 45(5):645-52. PubMed ID: 13032751
    [No Abstract]   [Full Text] [Related]  

  • 73. A study of the metabolism of 2,4-diaminopyrimidine.
    BENDICH A; GEREN WD; BROWN GB
    J Biol Chem; 1950 Jul; 185(1):435-8. PubMed ID: 15436516
    [No Abstract]   [Full Text] [Related]  

  • 74. Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.
    Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Takemura M
    Drug Target Insights; 2016; 10():1-7. PubMed ID: 26966348
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase II clinical trial of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine) and folinic acid (CF) in solid tumors.
    de Jager R; Brugarolas A; Hansen M
    Cancer Chemother Pharmacol; 1981; 6(1):81-4. PubMed ID: 6974059
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF).
    de Jager R; Dupont D; Rodzynek JJ; Dorlet C; Lagrange G
    Cancer Chemother Pharmacol; 1981; 6(1):75-80. PubMed ID: 6974058
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid.
    Alberto P; Peytremann R; Medenica R; Beretta-Piccoli M
    Cancer Chemother Pharmacol; 1978; 1(2):101-5. PubMed ID: 373910
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase.
    Nichol CA; Cavallito JC; Woolley JL; Sigel CW
    Cancer Treat Rep; 1977 Jul; 61(4):559-64. PubMed ID: 301777
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man.
    Cavallito JC; Nichol CA; Brenckman WD; Deangelis RL; Stickney DR; Simmons WS; Sigel CW
    Drug Metab Dispos; 1978; 6(3):329-37. PubMed ID: 26555
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of the lipid-soluble diaminopyrimidines, metoprine and etoprine, in the avian sarcoma virus rat glioma model.
    Serano RD; Sigel CW; Nichol CA; Bigner DD
    Cancer Treat Rep; 1982 Jan; 66(1):99-106. PubMed ID: 6272992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.